» Articles » PMID: 28666018

Indole-3-carbinol, a Plant Nutrient and AhR-Ligand Precursor, Supports Oral Tolerance Against OVA and Improves Peanut Allergy Symptoms in Mice

Overview
Journal PLoS One
Date 2017 Jul 1
PMID 28666018
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In general, dietary antigens are tolerated by the gut associated immune system. Impairment of this so-called oral tolerance is a serious health risk. We have previously shown that activation of the ligand-dependent transcription factor aryl hydrocarbon receptor (AhR) by the environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) affects both oral tolerance and food allergy. In this study, we determine whether a common plant-derived, dietary AhR-ligand modulates oral tolerance as well. We therefore fed mice with indole-3-carbinole (I3C), an AhR ligand that is abundant in cruciferous plants. We show that several I3C metabolites were detectable in the serum after feeding, including the high-affinity ligand 3,3´-diindolylmethane (DIM). I3C feeding robustly induced the AhR-target gene CYP4501A1 in the intestine; I3C feeding also induced the aldh1 gene, whose product catalyzes the formation of retinoic acid (RA), an inducer of regulatory T cells. We then measured parameters indicating oral tolerance and severity of peanut-induced food allergy. In contrast to the tolerance-breaking effect of TCDD, feeding mice with chow containing 2 g/kg I3C lowered the serum anti-ovalbumin IgG1 response in an experimental oral tolerance protocol. Moreover, I3C feeding attenuated symptoms of peanut allergy. In conclusion, the dietary compound I3C can positively influence a vital immune function of the gut.

Citing Articles

Atopic dermatitis and food allergy: More than sensitization.

Davis K, Claudio-Etienne E, Frischmeyer-Guerrerio P Mucosal Immunol. 2024; 17(5):1128-1140.

PMID: 38906220 PMC: 11471387. DOI: 10.1016/j.mucimm.2024.06.005.


Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation.

Chen Y, Wang Y, Fu Y, Yin Y, Xu K Cell Biosci. 2023; 13(1):85.

PMID: 37179416 PMC: 10182712. DOI: 10.1186/s13578-023-01046-y.


Modulation by luminal factors on the functions and migration of intestinal innate immunity.

Higashiyama M, Miura S, Hokari R Front Immunol. 2023; 14:1113467.

PMID: 36860849 PMC: 9968923. DOI: 10.3389/fimmu.2023.1113467.


Aryl hydrocarbon receptor: The master regulator of immune responses in allergic diseases.

Riaz F, Pan F, Wei P Front Immunol. 2023; 13:1057555.

PMID: 36601108 PMC: 9806217. DOI: 10.3389/fimmu.2022.1057555.


Inferred Causal Mechanisms of Persistent FMDV Infection in Cattle from Differential Gene Expression in the Nasopharyngeal Mucosa.

Zhu J, Stenfeldt C, Bishop E, Canter J, Eschbaumer M, Rodriguez L Pathogens. 2022; 11(8).

PMID: 35894045 PMC: 9329776. DOI: 10.3390/pathogens11080822.


References
1.
Soshilov A, Denison M . Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis. Mol Cell Biol. 2014; 34(9):1707-19. PMC: 3993610. DOI: 10.1128/MCB.01183-13. View

2.
van Wijk F, Hoeks S, Nierkens S, Koppelman S, van Kooten P, Boon L . CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization. J Immunol. 2004; 174(1):174-9. DOI: 10.4049/jimmunol.174.1.174. View

3.
Bhat P . Retinal dehydrogenase gene expression in stomach and small intestine of rats during postnatal development and in vitamin A deficiency. FEBS Lett. 1998; 426(2):260-2. DOI: 10.1016/s0014-5793(98)00355-x. View

4.
Yeste A, Nadeau M, Burns E, Weiner H, Quintana F . Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2012; 109(28):11270-5. PMC: 3396465. DOI: 10.1073/pnas.1120611109. View

5.
Rouse M, Rao R, Nagarkatti M, Nagarkatti P . 3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways. J Pharmacol Exp Ther. 2014; 350(2):341-52. PMC: 4109492. DOI: 10.1124/jpet.114.214742. View